B.Riley Financial Sticks to Their Buy Rating for Vaxart (VXRT)
According to TipRanks.com, Mamtani is a 5-star analyst with an average return of 26.9% and a 54.2% success rate. Mamtani covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Spectrum Pharmaceuticals, and Madrigal Pharmaceuticals.
Vaxart has an analyst consensus of Moderate Buy, with a price target consensus of $13.00.
See today’s analyst top recommended stocks >>
Based on the recent corporate insider activity of 13 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Biota Holdings Ltd. operates as an anti infective drug development firm. The company was founded on October 2, 1985 and is headquartered in Notting Hil, Australia.